Figure 2From: Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancerProbability of distant-free survival (DFS) (A) and overall survival (OS) (B) in pathologic complete response (pCR) and residual disease (RD) patients with triple negative breast cancers (TNBCs).Back to article page